<DOC>
	<DOCNO>NCT00238030</DOCNO>
	<brief_summary>To compare oral versus intravenous administration thyroid hormone : 1 ) reversibility hemodynamic instability organ donor , , 2 ) pharmacokinetics oral v iv thyroid administration</brief_summary>
	<brief_title>Thyroxine Replacement Organ Donors</brief_title>
	<detailed_description>Disruption hypothalamic-pituitary axis follow brain death may lead hemodynamic instability , peripheral vasodilation , diabetes insipidus organ donor , require use high dos inotropes . Inotropes may cause ischemic injury organ intramyocardial ATP store , result organ unsuitable transplantation , well , reduction post-transplant organ function . Therefore , clinician advocate use triple hormonal therapy potential organ donor . Since intravenous T3 ( intracellular active form thyroxine ) unavailable , oral intravenous T4 must use , require conversion T4 T3at cellular level . This conversion impede glucocorticoid also administer organ donor immunomodulating effect . Since oral T3 readily available , first question whether oral versus intravenous administration T4 comparable . If , next study determine efficacy oral T3 versus oral T4 . Our hypothesis oral T3 superior oral T4 . Our study therefore determine whether oral route suitable administration thyroid replacement therapy . The study compare pharmacokinetics oral versus intravenous T4 administration organ donor , well , determine ability wean intropes patient population .</detailed_description>
	<mesh_term>Brain Death</mesh_term>
	<criteria>1 . Brain death criterion establish 2 . Consent organ donation receive 1. immediate ( &lt; 4 Hrs ) organ retrieval anticipate</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>organ donation</keyword>
	<keyword>thyroid replacement</keyword>
</DOC>